Conversely, recombinant NGAL protected NGAL-R CLL cells against apoptosis by activating a STAT3/Mcl-1 signaling pathway. Our results suggest that NGAL and NGAL-R, overexpressed in untreated CLL, participate in the deregulation of the apoptotic machinery in CLL cells, and may be potential therapeutic clues for CLL treatment.
over 5 years ago
Journal
|
STAT3 (Signal Transducer And Activator Of Transcription 3) • LCN2 (Lipocalin-2)